ApoE4 and Alzheimer’s Risk: What Genetics Do and Do Not Decide

When a parent is diagnosed with Alzheimer’s disease, one of the first private questions an adult child may ask is:

“Does this mean I am going to get Alzheimer’s too?”

The fear becomes even stronger when families begin reading about APOE4, genetic risk, and inherited forms of Alzheimer’s.

A parent’s diagnosis does matter.

Family history can increase risk.

And the APOE ε4 variant is one of the strongest known genetic risk factors for the more common late-onset form of Alzheimer’s disease.

But those statements do not mean your future has already been decided.

Having APOE4 does not prove that you have Alzheimer’s.

It does not guarantee that you will develop Alzheimer’s.

And not having APOE4 does not guarantee that you will remain free of the disease.

That distinction is the most important thing to understand about ApoE4 Alzheimer’s risk.

At Michigan Cognitive Recovery Center at Lakeshore Woods Senior Living in Fort Gratiot, genetics may be considered as one part of a broader precision-medicine assessment when appropriate.

Genetic information is not interpreted alone.

It is considered alongside cognitive testing, medical history, symptoms, daily function, medications, laboratory findings, metabolic health, sleep, nutrition, vascular factors, and other information that may help build an individualized picture.

The goal is not to tell someone that a gene has determined their future.

The goal is to understand what genetic information can—and cannot—contribute to a broader assessment.

Key Takeaways

• APOE is a gene involved in lipid and cholesterol transport.
• APOE ε4, commonly called ApoE4, is a risk variant, not a diagnosis of Alzheimer’s disease.
• Having one copy of APOE4 generally increases Alzheimer’s risk compared with having no copies.
• Having two copies is generally associated with greater risk than having one.
• Neither one nor two copies guarantees that someone will develop Alzheimer’s.
• People without APOE4 can still develop Alzheimer’s disease.
• APOE-associated risk differs among individuals and populations, including by genetic ancestry.
• A family history of Alzheimer’s can increase risk without proving that the disease will be inherited.
• Rare mutations in genes such as APP, PSEN1, and PSEN2 can directly cause dominantly inherited Alzheimer’s, but these cases represent a very small proportion of Alzheimer’s disease.
• Routine APOE genetic testing is not generally recommended simply to predict whether a healthy person will someday develop Alzheimer’s.
• Genetic counseling can help families understand whether testing is appropriate and what a result actually means.
• At MCRC, genetics may be considered when appropriate as one component of a broader assessment rather than as a standalone explanation for cognitive decline.
• Genetic information does not replace cognitive testing, biomarker testing, medical evaluation, or physician-directed care.
• No genetic result can guarantee how an individual’s cognition will change over time.

A Quick ApoE4 and Alzheimer’s Genetics Checklist

Before interpreting a genetic result, families should be able to answer:

The Result

• Was APOE actually tested?
• Which APOE variants were reported?
• Does the person have zero, one, or two APOE ε4 copies?
• Was the result obtained through a clinical laboratory or consumer test?
• Has a qualified professional reviewed it?

What It Means

• Is this a risk variant or a disease-causing mutation?
• Does the result change estimated risk?
• Does it diagnose Alzheimer’s?
• Does it explain current memory symptoms?
• Does ancestry affect how the risk estimate should be interpreted?

Family History

• Which relatives developed dementia?
• At what ages did symptoms begin?
• Were diagnoses medically confirmed?
• Are there multiple cases of unusually early-onset Alzheimer’s?
• Is a rare inherited form being considered?

Current Cognitive Health

• Does the person actually have memory symptoms?
• Has cognitive testing been performed?
• Has daily function changed?
• Have medical causes of cognitive symptoms been evaluated?
• Are Alzheimer’s biomarkers clinically appropriate?

Next Steps

• Is genetic counseling appropriate?
• Would the result affect a medical decision?
• What other testing is needed?
• What modifiable health factors deserve attention?
• Who will interpret the complete picture?

Why Families Often Misunderstand Alzheimer’s Genetics

The word genetic sounds definitive.

Families may hear:

“Alzheimer’s has a genetic component.”

and interpret that as:

“My parent had Alzheimer’s, so I will get it too.”

Or they receive an APOE4 result and think:

“The test says I have the Alzheimer’s gene.”

Neither statement accurately describes how the most common form of Alzheimer’s usually works.

There is an important difference between:

A gene that increases risk

and

a rare genetic mutation that directly causes disease.

Understanding that difference is the starting point for interpreting genetic testing responsibly.

Understanding the ApoE4 Gene Meaning

1. What Is APOE?

APOE stands for apolipoprotein E.

The APOE gene contains instructions for making a protein involved in transporting cholesterol and other fats through the body.

Everyone inherits two APOE copies:

one from each biological parent.

The three common forms are:

• APOE ε2
• APOE ε3
• APOE ε4

Because each person inherits two copies, possible combinations include:

• ε2/ε2
• ε2/ε3
• ε2/ε4
• ε3/ε3
• ε3/ε4
• ε4/ε4

APOE ε3 is the most common form and is generally considered neutral in relation to Alzheimer’s risk.

APOE ε2 may be associated with lower risk in some people.

APOE ε4 is associated with increased risk of late-onset Alzheimer’s disease and, in some populations, an earlier average age of onset.

But APOE4 remains a risk factor.

It is not proof that Alzheimer’s will occur.

2. Is APOE4 the “Alzheimer’s Gene”?

Calling APOE4 “the Alzheimer’s gene” is misleading.

A more accurate description is:

APOE ε4 is an important genetic risk factor for late-onset Alzheimer’s disease.

That wording matters.

Someone can carry APOE4 for an entire lifetime without developing Alzheimer’s.

Someone with no APOE4 copies can still develop Alzheimer’s.

Therefore:

APOE4-positive does not mean Alzheimer’s-positive.

And:

APOE4-negative does not mean Alzheimer’s-proof.

A genetic result changes information about risk.

It does not independently diagnose disease or predict one person’s future with certainty.

3. What Does One Copy of ApoE4 Mean?

A person with one ε4 copy inherited that variant from one biological parent.

For example:

APOE ε3/ε4

Having one copy is generally associated with increased Alzheimer’s risk compared with having no ε4 copies.

But the size of that risk is not identical for every person.

Risk can be influenced by:

• Age
• Genetic ancestry
• Other genetic variants
• Cardiovascular health
• Blood pressure
• Diabetes
• Smoking
• Physical activity
• Sleep
• Other health conditions
• Environmental and social factors

This is why a single gene result should not be converted into a simple personal prediction.

The result tells you something about risk.

It does not tell you exactly what will happen.

4. What Does Having Two ApoE4 Copies Mean?

A person with:

APOE ε4/ε4

has inherited an ε4 copy from each biological parent.

Two APOE4 copies are generally associated with greater Alzheimer’s risk than one copy.

Research has also shown stronger associations with amyloid accumulation and earlier disease development in some populations.

However, even here, language must remain careful.

Having two APOE4 copies is associated with substantially increased risk.

It should not automatically be translated into:

“You definitely have Alzheimer’s.”

or:

“You definitely will develop Alzheimer’s.”

Individual outcomes vary, and APOE-associated risk is not identical across populations.

A genetic result requires clinical context.

ApoE4 Alzheimer’s Risk

5. How Much Does ApoE4 Increase Alzheimer’s Risk?

This question does not have one percentage that applies equally to everyone.

Research consistently shows a general pattern:

No ε4 copies → lower risk relative to carriers

One ε4 copy → increased risk

Two ε4 copies → greater risk

But individual risk estimates can vary substantially based on age, ancestry, sex, other genes, health factors, and the population being studied.

This is one reason families should be cautious about websites or consumer reports that present one percentage as though it predicts an individual person’s future.

The National Institute on Aging and Alzheimer’s Association both emphasize that APOE4 increases risk but does not determine whether someone will develop Alzheimer’s disease.

6. Why Does Ancestry Matter?

One of the reasons APOE4 risk cannot be reduced to one universal number is that its association with Alzheimer’s differs across populations.

Research has found that APOE ε4 does not appear to carry exactly the same degree of risk in every ancestral population.

That means a risk estimate developed largely from one population should not automatically be applied to every individual.

Genetics should therefore be interpreted within the broader clinical and ancestral context.

This is another reason genetic counseling can be valuable.

A genetic result may be technically correct while the interpretation attached to it is overly simplistic.

7. Can Someone Have ApoE4 and Never Develop Alzheimer’s?

Yes.

This is one of the most important facts in the entire discussion.

Some APOE4 carriers never develop Alzheimer’s disease.

The presence of a risk allele does not guarantee disease.

Likewise, many people who develop Alzheimer’s do not carry APOE4.

That is why APOE4 cannot be used by itself to answer:

“Will I get Alzheimer’s?”

The answer is not encoded in one genetic result.

Is Alzheimer’s Hereditary?

8. Does Having a Parent With Alzheimer’s Mean I Will Get It?

No.

Having a parent or sibling with Alzheimer’s is associated with increased risk compared with having no first-degree family history.

But increased risk is different from certainty.

Families can share:

• Genetic variants
• Cardiovascular risk factors
• Eating patterns
• Sleep habits
• Smoking exposure
• Physical-activity patterns
• Environmental exposures
• Social conditions

Family history therefore contains both genetic and non-genetic information.

A parent’s diagnosis should be part of your medical history.

It should not be treated as a prediction that the same outcome is unavoidable.

9. Is All Alzheimer’s Disease Inherited?

No.

Most Alzheimer’s disease is not caused by a single deterministic inherited mutation.

The most common form is late-onset Alzheimer’s, which usually reflects a complex combination of age, genetics, health factors, environment, and other influences.

This is different from rare families affected by autosomal dominant Alzheimer’s disease.

That distinction is extremely important.

10. What Is Familial or Autosomal Dominant Alzheimer’s?

Rare mutations in three genes are known to directly cause autosomal dominant Alzheimer’s disease:

• APP
• PSEN1
• PSEN2

These mutations can run strongly through families and often cause symptoms before age 65.

When a biological parent carries one of these disease-causing variants, each child has a 50% chance of inheriting that variant.

This is very different from inheriting APOE ε4.

APOE4 increases susceptibility.

A pathogenic mutation causing autosomal dominant Alzheimer’s carries a much more direct relationship with disease.

Dominantly inherited Alzheimer’s represents only a small minority of Alzheimer’s cases.

Families with multiple relatives developing Alzheimer’s unusually young should discuss that history with a neurologist or genetic counselor rather than assuming APOE testing answers the question.

Genetic Testing for Alzheimer’s

11. Should Everyone Get an ApoE4 Test?

No.

Routine APOE testing is not generally recommended simply to predict whether an asymptomatic person will eventually develop Alzheimer’s disease.

Why?

Because the result cannot tell someone with certainty whether they will develop the disease.

Testing can also create questions that are difficult to answer:

• What does my actual risk mean?
• Does this result change my medical care?
• Should my siblings get tested?
• What does this mean for my children?
• How will knowing affect my anxiety?
• Who should have access to the result?

Genetic information is information about both the person being tested and, indirectly, biological relatives.

That is why testing deserves more thought than ordering a routine cholesterol test.

12. When Can Genetic Testing Be Useful?

Genetic testing can be appropriate in specific clinical situations.

Examples may include:

Strong Early-Onset Family History

A neurologist or genetics specialist may consider testing for rare disease-causing genes when several relatives developed Alzheimer’s unusually early.

Treatment Decisions

In some clinical situations, APOE information may be considered alongside other medical factors when physicians evaluate treatment decisions because APOE ε4 status can affect the risk of amyloid-related imaging abnormalities, or ARIA.

The treating physician should determine whether testing is appropriate and explain how the result affects the treatment decision.

Research

APOE status is frequently used in Alzheimer’s research to understand differences in risk, disease biology, treatment response, and study populations.

Broader Personalized Assessment

Genetic information may also be considered alongside many other findings within certain precision-medicine frameworks.

But it should still be interpreted as one piece of information rather than a complete diagnosis.

13. Should I Use a Consumer Genetic Test?

Direct-to-consumer genetic testing may provide APOE information.

But receiving a result and understanding it are different things.

A consumer report may tell someone:

APOE ε3/ε4

without answering the questions that actually matter:

• How should this be interpreted for my ancestry?
• What is my actual absolute risk?
• Does my family history change the interpretation?
• Do my symptoms matter?
• Should testing be confirmed clinically?
• Does this result affect treatment?
• Should relatives be tested?
• What should I do next?

Someone considering APOE testing may benefit from discussing the decision with a physician or genetic counselor before testing—or before making medical decisions based on an existing consumer result.

14. Why Genetic Counseling Matters

Genetic counseling is not simply explaining what ε4 means.

A genetic counselor can help someone think through:

• Whether testing is appropriate
• What different results could mean
• Family history
• Early-onset patterns
• Risk versus certainty
• Whether confirmatory testing is appropriate
• Implications for biological relatives
• Emotional consequences of knowing
• Which questions should be taken back to a physician

The Alzheimer’s Association recommends genetic counseling when people are considering genetic testing for Alzheimer’s risk.

The decision to know your genetic status is personal.

It should be informed rather than driven by fear.

What ApoE4 Does Not Tell You

15. ApoE4 Does Not Diagnose Alzheimer’s Disease

An APOE4 result should never be treated as a standalone Alzheimer’s diagnosis.

Diagnosis may require a combination of:

• Medical history
• Cognitive assessment
• Neurological evaluation
• Daily-function assessment
• Laboratory testing
• Imaging when appropriate
• Alzheimer’s-specific biomarkers when appropriate
• Clinical interpretation

A person can be APOE4-positive and cognitively healthy.

A person can also have Alzheimer’s disease without APOE4.

If someone is experiencing memory changes, the next step should therefore be a proper evaluation—not simply ordering an APOE test.

Families can learn more in How Lab Testing and Biomarkers Shape a Personalized Cognitive Recovery Plan.

16. ApoE4 Does Not Explain Every Cognitive Symptom

Forgetfulness can have many possible contributors.

Examples include:

• Poor sleep
• Sleep apnea
• Depression
• Anxiety
• Medication effects
• Thyroid problems
• Vitamin deficiencies
• Metabolic problems
• Vascular disease
• Hearing loss
• Alcohol or substance use
• Acute illness
• Neurological disease

Finding APOE4 does not prove that APOE4 caused the person’s current symptoms.

That would confuse risk with diagnosis.

Cognitive symptoms still deserve a complete medical evaluation.

17. ApoE4 Does Not Tell You Which Treatment Will Work

A genetic result does not automatically determine a treatment plan.

Two APOE4 carriers may differ dramatically in:

• Cognitive stage
• Blood pressure
• Insulin resistance
• Lipids
• Sleep
• Nutrition
• Exercise
• Medications
• Cardiovascular disease
• Inflammation
• Nutrient status
• Daily function
• Other genetic factors

This is one reason personalized medicine looks beyond a single genetic result.

The question becomes:

What does the complete assessment show about this individual?

rather than:

What should every APOE4 carrier do?

Genetics Within a Precision-Medicine Approach

18. Where Does Genetics Fit Into Precision Medicine for Alzheimer’s?

Precision medicine attempts to use individual information to guide more personalized decisions.

That information may include:

• Medical history
• Cognitive testing
• Laboratory findings
• Genetics
• Medications
• Metabolic health
• Vascular health
• Nutrition
• Sleep
• Exercise
• Stress
• Environmental history
• Daily function

The purpose is not to treat every person with the same abnormality in exactly the same way.

It is to understand how multiple findings may fit together.

At MCRC, this broader framework is used within the ReCODE+ For Facilities Program™.

Families can read more about precision medicine and functional medicine approaches to Alzheimer’s.

19. Why the ReCODE Framework Looks Beyond ApoE4

The ReCODE framework views cognitive decline as potentially involving multiple overlapping contributors rather than one isolated factor.

MCRC’s existing guide to the 36 factors contributing to cognitive decline includes genetics and family history alongside other areas such as:

• Metabolic health
• Inflammation
• Nutrient status
• Hormonal factors
• Vascular health
• Sleep
• Environmental exposures
• Traumatic injury
• Other individualized factors

The presence of APOE4 therefore does not end the investigation.

It provides one piece of information that may be considered alongside the rest of the person’s clinical picture.

20. How Does Genetic Information Affect a Personalized Plan?

Genetic information is most useful when the question is:

“Does this finding change what qualified professionals need to consider?”

rather than:

“Is this gene the entire explanation?”

For example, genetic information might contribute to discussions involving:

• Overall Alzheimer’s risk
• Lipid and cardiovascular health
• Family history
• Appropriate monitoring
• Treatment-risk discussions
• Whether genetic counseling is indicated
• Whether additional evaluation is appropriate

It should not be used to justify unsupported treatments or guarantee outcomes.

The useful sequence is:

Genetic finding → clinical interpretation → broader assessment → appropriate decision

not:

Genetic finding → predetermined future

How MCRC Uses Testing

21. Where Does ApoE4 Testing Sit in the MCRC Workup?

At Michigan Cognitive Recovery Center, participants entering the 12-month ReCODE+ For Facilities Program™ begin with a broader assessment involving cognitive testing and comprehensive laboratory work.

The results are considered together with:

• Medical history
• Cognitive stage
• Symptoms
• Daily function
• Medications
• Lifestyle
• Laboratory findings
• Genetics when appropriate
• Other relevant clinical information

This distinction matters.

MCRC does not describe APOE status as a standalone diagnostic test for Alzheimer’s disease.

Genetic information may help inform risk and personalization, but it remains part of a larger assessment.

Read How Lab Testing and Biomarkers Shape a Personalized Cognitive Recovery Plan for a fuller explanation of the testing process.

22. Is ApoE4 the Same as an Alzheimer’s Biomarker?

Not exactly.

APOE4 is a genetic risk factor.

Alzheimer’s disease biomarkers are measures that may provide evidence about biological processes associated with the disease.

Examples can include measures related to:

• Amyloid
• Phosphorylated tau
• Other disease-associated processes

These answer different questions.

An APOE result may help describe inherited risk.

An Alzheimer’s biomarker may help evaluate whether certain disease-related biological changes are present.

Neither should be interpreted outside the broader clinical picture.

A person can carry APOE4 without having Alzheimer’s pathology.

That is why genetics and biomarkers should not be treated as interchangeable terms.

23. Why MCRC Does Not Build the Entire Plan Around Genetics

A personalized cognitive-health assessment should not stop after finding a genetic risk factor.

Genetics cannot be changed.

But many other areas of health can still be evaluated and medically managed.

Examples may include:

• Blood pressure
• Diabetes
• Sleep disorders
• Physical inactivity
• Smoking
• Cardiovascular health
• Nutritional deficiencies
• Medication effects
• Hearing problems
• Other medical conditions

Genetic risk therefore belongs in context.

A person should not be told:

“You have APOE4, so nothing else matters.”

Nor should they be told:

“Lifestyle guarantees that APOE4 will never affect you.”

Both statements go beyond what the evidence can support.

What Families Can Control

24. Does Genetic Risk Mean Prevention Is Pointless?

No.

Knowing that genetics influence risk does not mean other health factors are irrelevant.

Current dementia research identifies several modifiable factors associated with cognitive health, including areas such as:

• Blood pressure
• Diabetes
• Smoking
• Physical activity
• Cardiovascular health
• Sleep
• Cognitive and social engagement

These associations do not mean that any one lifestyle strategy can guarantee Alzheimer’s prevention.

There is no lifestyle program that can promise:

“Do this and you will never develop Alzheimer’s.”

The responsible message is different:

Genetics are one part of risk, while many aspects of general health remain worth managing regardless of APOE status.

25. Should I Live Differently if My Parent Had Alzheimer’s?

A parent’s diagnosis is a reasonable reason to pay attention to your own cognitive and general health.

But you do not need an APOE result before taking ordinary evidence-based health steps.

Discuss with your healthcare professional areas such as:

• Blood pressure
• Cholesterol
• Blood sugar
• Physical activity
• Sleep
• Smoking
• Hearing
• Depression
• Cardiovascular health
• Nutrition
• Cognitive concerns

If you are already noticing memory changes, do not assume they are simply genetic.

Request an appropriate evaluation.

Red Flags When Reading About ApoE4 Online

Be cautious when a website or program says:

• “APOE4 means you will get Alzheimer’s.”
• “You have the Alzheimer’s gene.”
• “A negative APOE4 test means you are safe.”
• “This genetic test diagnoses Alzheimer’s.”
• “Your parent had Alzheimer’s, so you will too.”
• “One supplement neutralizes APOE4.”
• “This diet guarantees APOE4 carriers will avoid dementia.”
• “Genetics do not matter at all.”
• “Lifestyle completely overrides genetics.”
• “Everyone should order an APOE test.”
• “You do not need genetic counseling.”
• “ApoE4 alone tells us what treatment you need.”
• “One abnormal genetic result explains your memory symptoms.”
• “Our program can guarantee that APOE4 will not lead to Alzheimer’s.”

Genetics deserve neither fatalism nor false reassurance.

Both can mislead families.

Questions to Ask Before Genetic Testing

Before requesting APOE or other Alzheimer’s-related genetic testing, ask:

• What specific gene are we testing?
• Why are we testing it?
• Is this a risk gene or a deterministic gene?
• Will the result change medical management?
• What could a positive result mean?
• What could a negative result mean?
• Could the result still leave major uncertainty?
• Should I speak with a genetic counselor first?
• Does my family history suggest a rare inherited form?
• Does age of onset in my family matter?
• How should ancestry be considered?
• Will the result need clinical confirmation?
• Who will interpret it?
• Does this test diagnose Alzheimer’s?
• Are other cognitive or biomarker tests more appropriate?
• What should happen after the result?

Testing is most useful when the family knows what question the test is supposed to answer.

How MCRC Answers the Main Genetics Questions

Based on current public program information and established Alzheimer’s genetics guidance:

Is APOE4 a Diagnosis?

No.

APOE ε4 is a genetic risk factor.

It does not by itself diagnose Alzheimer’s disease.

Does APOE4 Guarantee Alzheimer’s?

No.

Some APOE4 carriers never develop Alzheimer’s.

Can Someone Without APOE4 Develop Alzheimer’s?

Yes.

APOE4 is not required for Alzheimer’s disease to occur.

Do Two Copies Matter More Than One?

Generally, yes.

Two ε4 copies are associated with greater risk than one copy, but neither result should be interpreted as a guaranteed personal outcome.

Is Alzheimer’s Always Hereditary?

No.

Most Alzheimer’s disease is not caused by one deterministic inherited mutation.

Rare mutations in APP, PSEN1, and PSEN2 can cause autosomal dominant Alzheimer’s disease.

Should Every Adult Child of Someone With Alzheimer’s Get Tested?

No.

Routine APOE testing solely to predict future Alzheimer’s risk is not generally recommended.

Testing decisions should be individualized and may benefit from physician and genetic-counselor guidance.

How Does MCRC Use Genetics?

Genetics may be considered when appropriate alongside cognitive testing, laboratory results, medical history, symptoms, daily function, medications, lifestyle, and other information.

It is not treated as the complete explanation for cognitive decline.

What Happens After Testing?

Assessment findings may help inform a personalized ReCODE Report™ and broader plan within MCRC’s residential ReCODE+ program.

No genetic result or personalized plan can guarantee cognitive improvement.

A Simple Alzheimer’s Genetics Decision Scorecard

Rate each category from 1 to 5.

1 means the question has not been adequately answered.

5 means you understand the result, its limitations, and the next step.

Why Testing Is Being Considered

• The reason for testing is clear
• The specific test is identified
• The clinical question is understood
• The result could provide useful information

Family History

• Affected relatives are documented
• Ages of onset are known
• Early-onset cases have been identified
• Rare inherited Alzheimer’s has been considered when appropriate

Understanding ApoE4

• Risk is distinguished from certainty
• One copy and two copies are understood
• A negative result is not treated as zero risk
• Ancestry and individual variation are acknowledged

Clinical Context

• Cognitive symptoms have been evaluated
• Medical history has been reviewed
• Other possible contributors are considered
• Appropriate biomarkers are discussed separately

Professional Guidance

• A qualified clinician is involved
• Genetic counseling has been considered
• Results will be interpreted professionally
• Next steps are understood

Claims and Expectations

• Nobody has guaranteed disease
• Nobody has guaranteed prevention
• Nobody is using genetics as a standalone diagnosis
• Limitations of testing have been explained

A genetic test is most useful when it adds clarity.

If it produces a number without interpretation, the family may have more information but not necessarily more understanding.

Take the Next Step

If Alzheimer’s disease runs in your family or you are beginning to notice changes in memory, the first question does not have to be:

“Do I have ApoE4?”

A better starting point may be:

“What is happening with my cognition now, and what type of evaluation is appropriate?”

Michigan Cognitive Recovery Center at Lakeshore Woods Senior Living offers a structured assessment process within its 12-month ReCODE+ For Facilities Program™ for appropriate participants with subjective cognitive impairment, mild cognitive impairment, or early-stage Alzheimer’s disease.

The assessment considers cognitive testing, laboratory findings, medical history, symptoms, daily function, lifestyle factors, and genetics when appropriate.

Families interested in understanding memory changes can learn more about Memory Evaluation in Michigan: What Cognitive Testing Involves and When to Get One and contact MCRC to ask about the evaluation and candidacy process.

Michigan Cognitive Recovery Center
At Lakeshore Woods Senior Living
4851 Lakeshore Rd
Fort Gratiot, MI 48059
Phone: (810) 385-3185

Request a memory evaluation enquiry to discuss the appropriate next step.

Frequently Asked Questions

Medical Disclaimer

This article is for educational purposes only and does not constitute medical advice. The ReCODE Protocol™ and ReCODE+ For Facilities Program™ are not cures for Alzheimer’s disease, and individual results may vary. A clinical assessment by qualified MCRC staff is required before enrollment. The program does not replace evaluation, diagnosis, treatment, or ongoing care from licensed healthcare professionals. 

About the Author

This article was written by the Lakeshore Woods Team. Lakeshore Woods Senior Living in Fort Gratiot Township, Michigan, is home to Michigan Cognitive Recovery Center, one of only two U.S. senior living centers offering the ReCODE+ For Facilities Program™ in partnership with Apollo Health.